Sponsor:
Northwell Health
Code:
NCT04937244
Conditions
Malignant Glioma of Brain
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
5ALA exoscopic fluorescence filter
Brief summary:
Conditions
Malignant Glioma of Brain
Study ID
NCT04937244
Start date
May 13, 2021
Status verified date
Jun, 2021
Completion date
May 11, 2022
Anticipated
Primary completion date
May 11, 2022
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
10 participants
Anticipated
Intervention Model
Single group
Primary purpose
Device Feasibility
Arms
experimental: Patients with new or recurrent malignant gliomas
Interventions
5ALA exoscopic fluorescence filter
Primary outcome measure
Locations
Lenox Hill Hospital
Recruiting
New York, New York, United States, 10075
Contacts
Principal Investigator:
Randy D'Amico, MD
Sponsor
Northwell Health
Last update posted
Jun 23, 2021
Last verified
Jun, 2021
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Northwell Health on 2021-06-23.